CA2464615A1 - Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides - Google Patents

Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides Download PDF

Info

Publication number
CA2464615A1
CA2464615A1 CA002464615A CA2464615A CA2464615A1 CA 2464615 A1 CA2464615 A1 CA 2464615A1 CA 002464615 A CA002464615 A CA 002464615A CA 2464615 A CA2464615 A CA 2464615A CA 2464615 A1 CA2464615 A1 CA 2464615A1
Authority
CA
Canada
Prior art keywords
factor
related polypeptide
factor vii
vii
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002464615A
Other languages
English (en)
French (fr)
Inventor
Rasmus Rojkjaer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk Health Care AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2464615A1 publication Critical patent/CA2464615A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002464615A 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides Abandoned CA2464615A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Publications (1)

Publication Number Publication Date
CA2464615A1 true CA2464615A1 (en) 2003-05-15

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002464615A Abandoned CA2464615A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Country Status (16)

Country Link
EP (1) EP1446149A1 (xx)
JP (1) JP2005511599A (xx)
KR (1) KR20050043734A (xx)
CN (1) CN1596125A (xx)
AU (1) AU2002340779B2 (xx)
BR (1) BR0213953A (xx)
CA (1) CA2464615A1 (xx)
CZ (1) CZ2004543A3 (xx)
HU (1) HUP0401985A3 (xx)
IL (1) IL161544A0 (xx)
MX (1) MXPA04004304A (xx)
NO (1) NO20042380L (xx)
PL (1) PL370634A1 (xx)
RU (1) RU2004117534A (xx)
WO (1) WO2003039584A1 (xx)
ZA (1) ZA200403271B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100411684C (zh) 1999-07-14 2008-08-20 诺沃挪第克健康护理股份公司 FVIIa或组织因子拮抗剂在调节基因表达和细胞迁移或趋化中的应用
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
WO2005074974A1 (en) * 2004-02-05 2005-08-18 Novo Nordisk Health Care Ag Use of factor viia for treating late complications of trauma
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
WO2007104317A1 (en) * 2006-03-16 2007-09-20 Drugrecure Aps Methods for local treatment with factor vii
CN105848668A (zh) * 2013-11-04 2016-08-10 加利福尼亚大学董事会 治疗或预防与出血或低凝血相关联的病状的疗法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0756638B1 (en) * 1994-04-22 2001-04-04 Stichting Sanquin Bloedvoorziening Means for treating disorders in the blood coagulation cascade
WO1998058661A1 (en) * 1997-06-23 1998-12-30 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors

Also Published As

Publication number Publication date
WO2003039584A1 (en) 2003-05-15
IL161544A0 (en) 2004-09-27
HUP0401985A2 (hu) 2004-12-28
JP2005511599A (ja) 2005-04-28
MXPA04004304A (es) 2004-08-11
ZA200403271B (en) 2004-11-08
KR20050043734A (ko) 2005-05-11
AU2002340779B2 (en) 2007-08-02
EP1446149A1 (en) 2004-08-18
RU2004117534A (ru) 2005-05-10
PL370634A1 (en) 2005-05-30
NO20042380L (no) 2004-06-08
HUP0401985A3 (en) 2009-03-30
CN1596125A (zh) 2005-03-16
CZ2004543A3 (cs) 2004-08-18
BR0213953A (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
US7125846B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
US20050267014A1 (en) Pharmaceutical composition comprising factor VII polypeptides and tranexamic acid
US20070027077A1 (en) Pharmaceutical compositions comprising factor VII polypeptides and factor XI polypeptides
US7078479B2 (en) Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
US20060293241A1 (en) Pharmaceutical composition comprising a factor VII polypeptide and epsilon-aminocaproic acid
US20080069810A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides and TAFI Polypeptides
WO2003039585A1 (en) Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors
US20030119743A1 (en) Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors
AU2002354846B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
US20060030531A1 (en) Pharmaceutical composition comprising factor VII polypeptide and PAI-1 polypeptide
AU2002354846A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
US20080075709A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides And Thrombomodulin Polypeptides
AU2002340779B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
AU2002340779A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
AU2002340778B2 (en) Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides
EP1446147A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
WO2003039579A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
AU2002340778A1 (en) Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides
WO2003039589A1 (en) Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides
EP1446151A1 (en) Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued